24104211000001101: Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual medicinal product\Everolimus 2.5mg tablets\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Everolimus\Everolimus 2.5mg tablets\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Trade family\Afinitor\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing everolimus\Everolimus\Everolimus 2.5mg tablets\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing everolimus\Everolimus\Everolimus 2.5mg tablets\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing everolimus\Everolimus\Everolimus 2.5mg tablets\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing everolimus\Everolimus\Everolimus 2.5mg tablets\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ketone\Product containing everolimus\Everolimus\Everolimus 2.5mg tablets\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing macrolide\Product containing everolimus\Everolimus\Everolimus 2.5mg tablets\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing everolimus\Everolimus\Everolimus 2.5mg tablets\Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

78584201000001115 Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

78584301000001112 Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Everolimus 2.5mg tablets	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has active ingredient	Everolimus	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has specific active ingredient	Everolimus	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has excipient	Butylated hydroxytoluene	false	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Afinitor	true	Inferred relationship	Existential restriction modifier
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet 3 x 10 tablets	Has AMP	True	Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
78584201000001115	Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
78584301000001112	Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module